Thousands of messages to insurers

50,000+ people signed the #Coverage2Control petition and 12 major groups signed on as partners. JDRF hand-delivered your petitions to the 25 largest health insurance companies, and supporters sent thousands of personalized follow-up messages.

Artificial pancreas systems covered

All 25 of the nation’s largest health plans now cover artificial pancreas systems, including Anthem, which reversed its policy after hearing from JDRF and the T1D community.

Progress toward lower insulin costs

In 2018 UnitedHealthcare announced it would extend the drug discounts it receives to its members in fully insured commercial plans.  Pressure from the campaign prompted Aetna and Blue Cross Blue Shield of North Carolina to do so as well.  UnitedHealthcare then expended its program further, announcing that in 2020 all new employer plans would have to pass drug discounts through to the people who need the drugs.

JDRF has additionally called for drug companies to lower list prices and do more to help the uninsured access affordable insulin, and continues to be involved in ongoing conversations. JDRF continues to be deeply involved in ongoing conversations with Congress and the Administration about this important topic. Read our Congressional Testimony here.

Strongly Oppose Restrictions

After UnitedHealthcare announced it was extending its preferred insulin pump agreement to children as young as 7, we met with company leaders to urge them to reconsider this decision. Since then, we’ve encouraged our community to send a message to UHC that insurance restrictions like these are bad for people with T1D and our health system and tens of thousands of letters have been sent in as a result.  Your voices were heard – on July 1, 2020 UHC revised their policy.